Graham Wylie MRN
Dr. Graham Wylie has been an agent of change in the pharmaceutical industry for over 34 years. His career started at Pfizer, spanning clinical trial management, development of global technology platforms and global change management and continued at PAREXEL as a Medical Director and then Vice President of Account Management. He formed MRN as CEO in 2006, which has since become the market-leader of patient-centric and site-centric solutions for efficient, international clinical trial delivery. MRN’s integrated solutions have delivered over 100,000 in home trial visits across a network of over 2,600 sites in over 60 countries. In 2022, Graham became Executive Chairman for MRN. In this role, Graham is focused on continuing to find innovative ways to accelerate clinical trials, bringing drugs to market faster.